Key TakeawaysMFN’s future depends on political dynamics, with potential shifts if a Democrat succeeds Trump, focusing more on government price setting than international reference pricing.Implementing MFN in Medicare may face challenges, with potential economic compression in commercial payer negotiations and inherent limits on price differences.Tariffs on foreign-manufactured drugs could lead to increased costs for patients, […]

Author